Madeleine Kennedy

Madeleine Kennedy

Director/Board Member at NUFORMIX PLC

Net worth: 56 216 $ as of 30/06/2026

61 year
Health Technology
Communications
Commercial Services

Profile

Madeleine Elizabeth Kennedy is currently a Director at Nuformix Technologies Ltd., a Non-Executive Director at Nuformix Plc, and the Chief Financial Officer at Arquer Diagnostics Ltd., Genesis Technical Systems (UK) Ltd., and Tetris Pharma Ltd. Previously, she worked as the Finance Director at Alliance Pharma Plc, Principal at Nokia UK Ltd. and Serco, Inc., Chief Financial Officer at Lab 21 Ltd., Akamis Bio Ltd., and Ieso Digital Health Ltd., and as a Principal at McCann Erickson (Germany).
From 2019 to 2021, she served as the Chief Financial Officer & Director at MyHealthChecked Plc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/11/2025 23,521,428 ( 0.9% ) 56 216 $ 30/06/2026

Madeleine Kennedy active positions

CompaniesPositionStart
NUFORMIX PLC Director/Board Member 02/12/2020
Director of Finance/CFO -
Director of Finance/CFO -
Director of Finance/CFO -
Director/Board Member -

Former positions of Madeleine Kennedy

CompaniesPositionEnd
FORTIS FRONTIER PLC Director of Finance/CFO 04/06/2021
Director of Finance/CFO 01/11/2010
Director of Finance/CFO -
Director of Finance/CFO -
░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ -
See the detail of Madeleine Kennedy's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Communications

Commercial Services

Health Services

Industrial Services

Health Services

Health Technology

Commercial Services

Health Technology

Communications

Health Technology

Health Technology

Distribution Services

  1. Stock Market
  2. Insiders
  3. Madeleine Kennedy